Pharma Journalist - Page 76 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

ABL Bio Signs License Deal with GSK for Grabody-B Brain Delivery Platform

CAS and Cleveland Clinic Collaborate to Boost Research with AI and Quantum Computing

Ethris and Lonza Partner on Spray-Dried mRNA Vaccines for Respiratory Diseases

UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease

Sangamo and Lilly Partner on Capsid License for CNS Genomic Medicines

Boehringer Ingelheim Expands ADC Portfolio with New R&D Center in Basel

Neurona Therapeutics Raises $102M for NRTX-1001 Phase 3 Trial

Rilzabrutinib Receives Orphan Drug Designation for Two Rare Diseases

Novartis Gets FDA Accelerated Approval for Vanrafia in IgAN

Flagship Pioneering and Pfizer Partner to Develop Selective Inhibitors for Autoimmune Diseases